About Avery Pharmaceuticals
Avery Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 2019. A specialty pharmaceutical company focusing on innovative drug delivery systems and patient care enhancements through Mouth Dissolving Strips technology. The company has 41 employees. Its Indian entity Avery Pharmaceuticals Private Limited reported revenue of ₹1.83 Cr. Avery Pharmaceuticals offers products and services including Mouth Dissolving Strips and Drug Delivery Solutions. Its focus areas include Manufacturing, Pharmaceutical Manufacturing, Oral Dosage Forms and Fast Dissolving Films.
Company details
Avery Pharmaceuticals is recognized as a specialty pharmaceutical company that operates as a wholly-owned subsidiary of Arrow Greentech Limited, with a commitment to improving patient outcomes through the development of Mouth Dissolving Strips for oral drug administration. These strips are designed to dissolve quickly upon contact with saliva, enabling faster drug release and absorption without requiring additional fluids. The companys manufacturing is supported by advanced infrastructure that adheres to global standards, while research efforts are led by teams of experts focusing on innovative solutions for unmet medical needs. Overall, efforts are directed towards sustainable healthcare advancements, emphasizing quick and effective drug delivery methods.
- Headquarters Mumbai, India
- Employees 41
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website averypharma.co.in
- Legal Name Avery Pharmaceuticals Pvt Ltd
- Date of Incorporation 29 May, 2017
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1.83 Cr
FY 2025 · +42% YoY
- Net Loss-₹4.74 Cr
FY 2025 · -259% margin
- EBITDA-₹2.65 Cr
FY 2025 · -145% margin
- Employee Count41
Associated legal entities of Avery Pharmaceuticals
Avery Pharmaceuticals operates through Avery Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Avery Pharmaceuticals Private Limited CIN U74999MH2017PTC295476 | Active | 29 May 2017 | Mumbai, Maharashtra | ₹1.8 Cr | 41 | 2 | View details |
Products & Services of Avery Pharmaceuticals
Avery Pharmaceuticals offers a comprehensive portfolio of products and services, including Mouth Dissolving Strips and Drug Delivery Solutions.
These strips are designed for quick dissolution in the mouth to facilitate rapid drug absorption and bioavailability without the need for additional fluids.
Innovative solutions are provided for oral drug administration that address unmet medical needs through advanced formulation techniques.
Board of directors of Avery Pharmaceuticals Private Limited (Avery Pharmaceuticals)
Avery Pharmaceuticals Private Limited is the primary company behind Avery Pharmaceuticals. The board of Avery Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Shilpan Pravin Patel, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shilpan Pravin Patel DIN 00341068 | Director | 29 May 2017 | 9 yrs 5 mo | Avery Pharmaceuticals Private Limited |
| Neil Shilpan Patel DIN 00607101 | Director | 29 May 2017 | 9 yrs 5 mo | Avery Pharmaceuticals Private Limited |
Financials of Avery Pharmaceuticals
Figures of Avery Pharmaceuticals Private Limited, the primary company behind Avery Pharmaceuticals, for FY 2025. Revenue was ₹1.83 Cr (+42% year on year). Net loss was -₹4.74 Cr (-259% margin). EBITDA was -₹2.65 Cr (-145% margin).
- ₹1.83 CrRevenue · FY 2025 · +42% YoY
- -₹4.74 CrNet loss · -259% margin
- -₹2.65 CrEBITDA · -145% margin
- ₹71.5 LakhPaid-up capital
- 41Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Avery Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Avery Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avery Pharmaceuticals
Complete news archive for Avery Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avery Pharmaceuticals
Avery Pharmaceuticals was founded in 2019.
Avery Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Avery Pharmaceuticals has 41 employees.
The primary company behind Avery Pharmaceuticals, Avery Pharmaceuticals Private Limited, reported revenue of ₹1.83 Cr for FY 2025, up 42% year on year.
Avery Pharmaceuticals is recognized as a specialty pharmaceutical company that operates as a wholly-owned subsidiary of Arrow Greentech Limited, with a commitment to improving patient outcomes through the development of Mouth Dissolving Strips for oral drug administration. These strips are designed to dissolve quickly upon contact with saliva, enabling faster drug release and absorption without requiring additional fluids. The companys manufacturing is supported by advanced infrastructure that adheres to global standards, while research efforts are led by teams of experts focusing on innovative solutions for unmet medical needs. Overall, efforts are directed towards sustainable healthcare advancements, emphasizing quick and effective drug delivery methods.
Avery Pharmaceuticals offers Mouth Dissolving Strips and Drug Delivery Solutions.
Avery Pharmaceuticals operates through Avery Pharmaceuticals Private Limited.
The legal entities of Avery Pharmaceuticals currently have 2 directors, including Shilpan Pravin Patel, Neil Shilpan Patel.